Renalytix Share Discussion Threads

[74tom] 20/5/2020 14:31

This is going to be absolutely huge, so many amazing quotes in this press release from Bio-Techne.



"Through Kantaro's partnership with Bio-Techne, we look forward to bringing this extremely high-quality test to every corner of the globe, so that COVID-19 can be monitored and isolated."

“As the world leader in ELISA assays, Bio-Techne has substantial capacity and the ability to scale production levels to support much of our nation's needs.”

“Initial kit production capacity is expected to enable laboratories to conduct in excess of 10 million tests monthly in July, scaling to higher capacity in subsequent months.”

[74tom] 20/5/2020 10:58

Bought in this morning, NASDAQ listing alone should see this much higher - it was £3.70 in December.

[sspurt] 20/5/2020 10:33

I'm still here - its also in my 2020 naps

[toffeeman] 20/5/2020 10:30

There are a few of us!

(In via Guinness AIM EIS)

[nimbo1] 20/5/2020 10:10

there is a lot happening here.

Nasdaq listing
Spin off
New business line announced today

Also no PI's here it seems...

[bubbleandleek] 20/5/2020 09:55

i'm going by the N+1 note this morning and yes, this would be solely to RENX. Although N+1 are being very conservative in their estimates IMO

[nimbo1] 20/5/2020 09:53

I've just been buying a lot more shares.

N+1 singer estimate this is a $50 mil additional revenue line for renx annualised as bubbleandleek says. 10 mil tests per month by July @ $400 a test a real possibility...

I was here for the other parts of the business but this is an exciting sideline!

[nimbo1] 20/5/2020 09:28

where do you get the news from ref 4mil a month? would that be to the new venture or renx - renx have 25% of new venture from rns.

[bubbleandleek] 20/5/2020 08:49

very quiet on here considering the news today. i hear this could be worth in the region of £4m a month in recurring income..... which will take them past 2021 broker estimates for this alone.... then you have the main part of the business.... and then they haven't even started on the diabetes testing.... oh, and the nasdaq listing!! when all is said and done these could easily be 1500 within the next couple of years. any thoughts?

[wan] 20/5/2020 07:32

More good news from Renalytix. This time beyond the stated strategy, but importantly utilising the partners combined strengths. In turn, strengthening and demonstrating the important bond.

[intrinsicinvestor] 18/5/2020 09:17

Yes, it seems highly likely that some money will be raised. It will be interesting to see how much or if it's token to provide some liquidity.Presumably the spin off will take place ASAP and before the new listing.

[wan] 18/5/2020 07:59

It's also a public offering, so one assumes it's a potential capital raise too?

[nimbo1] 18/5/2020 07:10

This announcement contains inside information

Renalytix AI plc
("RenalytixAI", the "Company")

Proposed dual-listing on Nasdaq

Renalytix AI plc (LSE: RENX), a commercial-stage artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and lower healthcare costs, announces that it has confidentially submitted a draft registration statement on Form F-1 with the Securities and Exchange Commission (the "SEC") relating to a proposed dual-listing and public offering of American Depositary Shares, each of which will represent one or a number of the Company's ordinary shares, on the Nasdaq Stock Market (the "Offering").

[saints98] 12/5/2020 15:00

New initiation from Investec with 523p price target.

[wan] 12/5/2020 13:09

I challenged Barclays Smart Investor today,as they are still listing Renalytix as restricted (unable to buy and offering a sell as the only option).

They have come back to me and said that it had already been escalated by others, and that they checked again today and Crest has still 'not' yet removed the restriction!

[intrinsicinvestor] 05/5/2020 13:14

Hopefully there will be a subscription option for shareholders too. I significantly added to my RENX holding at that time.

[wan] 05/5/2020 12:36

I can tell you from a very poor experience, that not just Americans were excluded from buying the shares, but UK investors too i.e. those of us who are with incompetent brokers that were unable to differentiate their US clients from their UK clients, which beggars belief considering the personal information that they hold!

It's a shame that this was not done much earlier and hopefully this will apply to the demerger (if completed)of Fractal Dx into Verici Dx

My EKF Renalytix demerger holding remains fully intact/invested.

[charlieej] 05/5/2020 11:44

Looking at how well it paid off for EKF investors when they split out RENX it's not a bad shout. Also if I understand today's news correctly it opens up RENX purchases to Americans who in my opinion will be more likely to value the business higher on the news so far. Medicare and fda breakthrough device news in my opinion particularly undervalued at the moment

[cambridgedon] 05/5/2020 08:20

Hi All,
Hope you are all surviving these difficult times.
Re: the demerger of the new enterprise. Does anyone know what the cut off date is for qualifying for new shares?
The General Meeting is on 15th May and the effective date is 10th June.
Given the performance of RENX it might be a good plan to acquire some more now to qualify for extra shares. Any thoughts on this?
CD

[wan] 29/4/2020 14:01

Off the radar somewhat currently, but Renalytix continues to make good progress.

Plus we have a potential demerger for good measure, which the market appears to be waking up to.

[digger18] 27/4/2020 09:24

Does anyone have any idea approximately when an FDA update is expected? I can’t seem to find anything in the RNS history?

[wan] 15/4/2020 08:04

Very pleased to see further strategic progress being made.